compounding glp 1 ban New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our The growing availability of compounded

As the most pharmacologically complex compound in the Velox Peptides catalogue, Retatrutide is primarily of interest to researchers studying multi-receptor metabolic signalling, incretin biology, and energy homeostasis

Modelling dynamics in protein crystal structures by ensemble refinement

Even moderate drinking can provoke episodes in some people, and binge drinking is well-recognised enough as a trigger to have its own term, holiday heart

Sleep and Stress Sleep quality and stress levels can influence hormones related to hunger and fat storage

doi: 10.1146/annurev-immunol-030409-101323 6 AndroulakisI

Detoxes and Cleanses: What You Need To Know